S. Endo

发表

Successful Treatment with Modified FOLFOX6 and Panitumumab in a Cecal Cancer Patient Undergoing Hemodialysis.

I. Hyodo, T. Moriwaki, A. Sugaya, 2016, Internal medicine.

Risk factors for submucosal and lymphovascular invasion in gastric cancer looking indicative for endoscopic submucosal dissection

I. Hyodo, Hideo Suzuki, T. Narasaka, 2014, Gastric Cancer.

Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy

I. Hyodo, Yoshiyuki Yamamoto, M. Gosho, 2016, British Journal of Cancer.

MDM4 expression as an indicator of TP53 reactivation by combined targeting of MDM2 and MDM4 in cancer cells without TP53 mutation

I. Hyodo, K. Yamato, Y. Natori, 2014, Oncoscience.

Hepatocellular adenoma in a woman who was undergoing testosterone treatment for gender identity disorder

A. Tsubota, H. Hano, Keizo Kato, 2018, Clinical Journal of Gastroenterology.

Enhanced G1 arrest and apoptosis via MDM4/MDM2 double knockdown and MEK inhibition in wild-type TP53 colon and gastric cancer cells with aberrant KRAS signaling

I. Hyodo, K. Yamato, Yoshiyuki Yamamoto, 2021, Oncology letters.

A phase I study of doxifluridine combined with weekly paclitaxel for metastatic gastric cancer

I. Hyodo, S. Hirasaki, J. Nasu, 2005, Cancer Chemotherapy and Pharmacology.

Phase I study of gemcitabine, cisplatin, and S‐1 combination therapy for patients with untreated advanced biliary tract cancer

I. Hyodo, T. Moriwaki, N. Hasegawa, 2015, Journal of hepato-biliary-pancreatic sciences.

Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis.

H. Matsui, I. Hyodo, A. Yanaka, 2013, World journal of gastroenterology.

A phase I study of S-1 combined with weekly cisplatin for metastatic gastric cancer in an outpatient setting.

H. Tajiri, I. Hyodo, J. Nasu, 2003, European journal of cancer.

Predicting skin toxicity according to EGFR polymorphisms in patients with colorectal cancer receiving antibody against EGFR.

I. Hyodo, K. Yamato, Hideo Suzuki, 2013, Anticancer research.

Granular cell tumor occurring in the sigmoid colon treated by endoscopic mucosal resection using a transparent cap (EMR-C)

I. Hyodo, S. Hirasaki, T. Doi, 2003, Journal of Gastroenterology.

Gastric Adenocarcinoma with Dual Differentiation toward Neuroendocrine and α-Fetoprotein-Producing Features: Report of 2 Cases

Y. Ueda, S. Ban, Y. Yamagata, 2017, Case Reports in Gastroenterology.

A case of hepatocellular carcinoma caused severe tumor lysis by ramucirumab

Keizo Kato, H. Abe, Makiko Ika, 2021, Kanzo.

Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin‐3 in gastric cancer cells

I. Hyodo, K. Yamato, Hideo Suzuki, 2011, Cancer science.

MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53

I. Hyodo, K. Yamato, Yoshiyuki Yamamoto, 2021, AntiCancer Research.

Antitumor Effects of a Sirtuin Inhibitor, Tenovin-6, against Gastric Cancer Cells via Death Receptor 5 Up-Regulation

I. Hyodo, K. Yamato, Hideo Suzuki, 2014, PloS one.

Newly developed endoscopic detachable snare ligation therapy for colonic diverticular hemorrhage: a multicenter phase II trial (with videos).

I. Hyodo, T. Narasaka, K. Matsuda, 2018, Gastrointestinal endoscopy.

The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.

I. Hyodo, K. Yamato, Hideo Suzuki, 2014, Oncology research.

Effectiveness of an endoscopic biopsy procedure using EUS-FNA and EMR-C for diagnosing adenocarcinoma arising from ectopic pancreas: two case reports and a literature review.

I. Hyodo, Yoshiyuki Yamamoto, Hideo Suzuki, 2014, Internal medicine.

Cancer-related FGFR2 overexpression and gene amplification in Japanese patients with gastric cancer

H. Kiyozaki, K. Minashi, K. Amagai, 2021, Japanese journal of clinical oncology.

Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER)

I. Hyodo, M. Shimada, Kazuma Kobayashi, 2019, International Journal of Clinical Oncology.

Augmented antitumor activity of 5‐fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells

I. Hyodo, K. Yamato, Yoshiyuki Yamamoto, 2019, Cancer science.

High Orotate Phosphoribosyltransferase Gene Expression Predicts Complete Response to Chemoradiotherapy in Patients with Squamous Cell Carcinoma of the Esophagus

Y. Hiasa, I. Hyodo, B. Matsuura, 2009, Oncology.

Survival analysis of platinum-refractory patients with advanced esophageal cancer treated with docetaxel or best supportive care alone: a retrospective study.

I. Hyodo, Yoshiyuki Yamamoto, T. Matsumoto, 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Panitumumab-Induced Interstitial Lung Disease in a Case of Metastatic Colorectal Cancer

I. Hyodo, Yoshiyuki Yamamoto, T. Moriwaki, 2013, Oncology Research and Treatment.

Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER)

I. Hyodo, M. Shimada, Kazuma Kobayashi, 2019, International Journal of Clinical Oncology.

E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer

I. Hyodo, H. Hamada, K. Yokoyama, 2009, Cancer Gene Therapy.

High Orotate Phosphoribosyltransferase Gene Expression Predicts Complete Response to Chemoradiotherapy in Patients with Squamous Cell Carcinoma of the Esophagus

Y. Hiasa, I. Hyodo, B. Matsuura, 2009, Oncology.

C-Arm Cone Beam Computed Tomography Guidance for Radiofrequency Ablation in Hepatocellular Carcinoma

A. Tsubota, Keizo Kato, H. Abe, 2017, Oncology.